Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

18.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 70.00
  • 52 Week Low: 12.00
  • Currency: UK Pounds
  • Shares Issued: 92.53m
  • Volume: 463,542
  • Market Cap: £17.12m
  • RiskGrade: 747

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-21 Interim n/a (2.81) (3.00)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 2.62 (7.58) (35.36)p n/a n/a n/a n/a 0.0%
30-Jun-18 1.94 (7.79) (37.24)p n/a n/a n/a n/a 0.0%
30-Jun-19 2.36 (4.52) (13.87)p n/a n/a n/a n/a 0.0%
30-Jun-20 1.06 (20.38) (54.48)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.69 (1.85) (1.19)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 n/a n/a n/a n/a n/a n/a n/a 0.0%
30-Jun-23 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genedrive Market Data

Currency UK Pounds
Share Price 18.50p
Change Today -1.00p
% Change -5.13 %
52 Week High 70.00
52 Week Low 12.00
Volume 463,542
Shares Issued 92.53m
Market Cap £17.12m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.99% below the market average34.99% below the market average34.99% below the market average34.99% below the market average34.99% below the market average
52.63% below the sector average52.63% below the sector average52.63% below the sector average52.63% below the sector average52.63% below the sector average
Price Trend
91.38% below the market average91.38% below the market average91.38% below the market average91.38% below the market average91.38% below the market average
79.49% below the sector average79.49% below the sector average79.49% below the sector average79.49% below the sector average79.49% below the sector average
Income Not Available
Growth
60.96% below the market average60.96% below the market average60.96% below the market average60.96% below the market average60.96% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

Genedrive Dividends

No dividends found

Trades for 27-Jun-2022

Time Volume / Share Price
16:21 26,775 @ 18.63p
16:16 10,000 @ 18.25p
16:11 5,409 @ 18.49p
16:09 40,000 @ 18.29p
15:58 26,780 @ 18.67p

Genedrive Key Personnel

CEO David Budd
CFO Russell Shaw

Top of Page